![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25623-25631, September 3, 1999
,
,
From the 9-O-Acetylation is one of the most
common modifications of sialic acids, and it can affect several sialic
acid-mediated recognition phenomena. We previously reported a cDNA
encoding a lysosomal sialic acid-specific
9-O-acetylesterase, which traverses the endoplasmic reticulum-Golgi pathway and localizes primarily to lysosomes and endosomes. In this study, we report a variant cDNA derived from the
same gene that contains a different 5' region. This cDNA has a
putative open reading frame lacking a signal peptide-encoding sequence
and is thus a candidate for the previously described cytosolic sialic
acid 9-O-acetylesterase activity. Epitope-tagged constructs
confirm that the new sequence causes the protein product to be targeted
to the cytosol and has esterase activity. Using reverse
transcription-polymerase chain reaction to distinguish the two forms of
message, we show that although the lysosomal sialic acid-specific
9-O-acetylesterase message has a widespread pattern of
expression in adult mouse tissues, this cytosolic sialic acid
9-O-acetylesterase form has a rather restricted
distribution, with the strongest expression in the liver, ovary, and
brain. Using a polyclonal antibody directed against the 69-amino acid region common to both proteins, we confirmed that the expression of
glycosylated and nonglycosylated polypeptides occurred in appropriate subcellular fractions of normal mouse tissues. Rodent liver
polypeptides reacting to the antibody also co-purify with previously
described lysosomal sialic acid esterase activity and at least a
portion of the cytosolic activity. Thus, two sialic acid
9-O-acetylesterases found in very different subcellular
compartments can be encoded by a single gene by differential usage of a
signal peptide-encoding exon at the N terminus. The 5'-rapid
amplification of cDNA ends results and the differences in
tissue-specific expression suggest that expression of these two
products may be differentially regulated by independent promoters.
Glycobiology Research and Training Center,
Divisions of Hematology-Oncology and Cellular and Molecular Medicine,
University of California San Diego, La Jolla, California 92093 and the
§ Ontario Cancer Institute, University of Toronto,
Ontario M5G 2M9, Canada
This article has been cited by other articles:
![]() |
Y. Naito, H. Takematsu, S. Koyama, S. Miyake, H. Yamamoto, R. Fujinawa, M. Sugai, Y. Okuno, G. Tsujimoto, T. Yamaji, et al. Germinal Center Marker GL7 Probes Activation-Dependent Repression of N-Glycolylneuraminic Acid, a Sialic Acid Species Involved in the Negative Modulation of B-Cell Activation Mol. Cell. Biol., April 15, 2007; 27(8): 3008 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tribl, M. Gerlach, K. Marcus, E. Asan, T. Tatschner, T. Arzberger, H. E. Meyer, G. Bringmann, and P. Riederer "Subcellular Proteomics" of Neuromelanin Granules Isolated from the Human Brain Mol. Cell. Proteomics, July 1, 2005; 4(7): 945 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Malisan, L. Franchi, B. Tomassini, N. Ventura, I. Condo, M. R. Rippo, A. Rufini, L. Liberati, C. Nachtigall, B. Kniep, et al. Acetylation Suppresses the Proapoptotic Activity of GD3 Ganglioside J. Exp. Med., December 16, 2002; 196(12): 1535 - 1541. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |